Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
The cyclic production of estrogen and progesterone by the premenopausal ovary accounts for the steep rise in breast cancer risk in premenopausal women. These hormones are breast cell mitogens. By reducing exposure to these ovarian hormones, agonists of luteinizing hormone-releasing hormone (LHRH) gi...
Na minha lista:
| 發表在: | Breast Cancer Res |
|---|---|
| Principais autores: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2000
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138786/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11250719/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr67 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|